Bibliography

Export 8 results:
Filters: Keyword is Graft vs Host Disease  [Clear All Filters]
2010
Defabianis P, Braida S, Guagnano R. 180-day screening study for predicting the risk factors for developing acute oral Graft-versus-Host disease in paediatric patients subjected to allogenic haematopoietic stem cells transplantation. Eur J Paediatr Dent. 2010;11(1):31-4.
2008
Kaul DR, Lowe L, Visvesvara GS, Farmen S, Khaled YA, Yanik GA. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transpl Infect Dis. 2008;10(6):437-41.
Haspel RL, Miller KB. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther. 2008;3(4):229-36.
2007
Worel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A, et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci. 2007;36(3):297-304.
2004
El-Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004;103(12):4674-80.
Pallera AM, Schwartzberg LS. Managing the toxicity of hematopoietic stem cell transplant. J Support Oncol. 2004;2(3):223-37; - discussion - 237-8, - 241, - 246-7.
1999
Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94(4):1465-70.
1986
Blazar BR, Lasky LC, Perentesis JP, Watson KV, Steinberg SE, Filipovich AH, et al. Successful donor cell engraftment in a recipient of bone marrow from a cadaveric donor. Blood. 1986;67(6):1655-60.